Literature DB >> 16684216

Sorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure.

Stephen R Ash1, Thomas A Sullivan, David J Carr.   

Abstract

Hepatic failure is a significant medical problem which has been unsuccessfully treated by hemodialysis. However, similar therapies using recirculated dialysate regenerated by sorbents in place of single-pass dialysate have been beneficial in treating acute-on-chronic liver failure. The advantages of sorbent-based treatments include some selectivity of toxin removal and improved removal of protein-bound toxins. Activated carbon has been extensively used in detoxification systems, but has often had insufficient toxin capacity. Powdered activated carbon, because of its large surface area, can provide greater binding capacity for bilirubin and other toxins than granular carbon commonly used in detoxifying columns. Methods of using powdered carbon in extracorporeal blood treatment devices are reviewed in the present paper, including liver dialysis and a new sorbent suspension reactor (SSR); and the abilities and limitations of the SSR and columns to process protein solutions are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684216     DOI: 10.1111/j.1744-9987.2006.00356.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

Review 1.  A peritoneal-based automated wearable artificial kidney.

Authors:  David B N Lee; Martin Roberts
Journal:  Clin Exp Nephrol       Date:  2008-04-03       Impact factor: 2.801

2.  Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

Authors:  John F Patzer
Journal:  Artif Organs       Date:  2008-07       Impact factor: 3.094

3.  Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.

Authors:  Apeksha Damania; Mohsin Hassan; Nana Shirakigawa; Hiroshi Mizumoto; Anupam Kumar; Shiv K Sarin; Hiroyuki Ijima; Masamichi Kamihira; Ashok Kumar
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

Review 4.  Recent trends in therapeutic application of engineered blood purification materials for kidney disease.

Authors:  Cui Gao; Qian Zhang; Yi Yang; Yangyang Li; Weiqiang Lin
Journal:  Biomater Res       Date:  2022-02-04

5.  An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.

Authors:  Susan R Sandeman; Carol A Howell; Gary J Phillips; Yishan Zheng; Guy Standen; Robert Pletzenauer; Andrew Davenport; Kolitha Basnayake; Owen Boyd; Stephen Holt; Sergey V Mikhalovsky
Journal:  J Mater Sci Mater Med       Date:  2014-02-27       Impact factor: 3.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.